Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis

Thorax

Volumn 57, Issue 8, 2002, Pages 749-750

  Parmar, J S ^a   Howell, T ^a   Kelly, J ^a   Bilton, D ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CORTICOSTEROID; CORTICOTROPIN; FLUTICASONE; ITRACONAZOLE; METHYLPREDNISOLONE; TETRACOSACTIDE;

ADRENAL SUPPRESSION; ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHOPULMONARY ASPERGILLOMA; CASE REPORT; CUSHING SYNDROME; CYSTIC FIBROSIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LUNG FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STEROID THERAPY; STEROIDOGENESIS;

ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CUSHING SYNDROME; DRUG INTERACTIONS; HUMANS; ITRACONAZOLE; MALE;

EID: 0036343883     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.8.749     Document Type: Article

References (10)

1. Transient pulmonary infiltrates in CF due to allergic aspergillosis
2. ABPA in CF
3. A rise in IgE as an indicator of ABPA in CF
4. Effects of itraconazole therapy in ABPA
5. A randomised trial of itraconazole in allergic bronchopulmonary aspergillosis
6. Pharmacology of fluticasone propionate
7. Total suppression of cortisol excretion by ketaconazole in the therapy of ectopic ACTH syndrome
8. Effects of antifungal agents on oxidative metabolism
9. Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteers
10. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma